Monographie - Infliximab - Stabilis 4.0

Son güncelleme :
19/11/2024

Immünosupresan

Infliximab

Enjeksiyon

Göz damlası

Çözeltilerin stabilitesi

Karışımlardaki stabilitesi

Stabiliteyi etkileyen faktörler

Uyumluluk

Uygulama yöntemi

Kaynaklar

pdf

Ticari isim

Ticari isim

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Flixabi	Almanya, Belçika, Büyük Britanya, İspanya
Flixceli	Peru
Inflectra	Almanya, Belçika, Büyük Britanya, İspanya, İsviçre, İtalya, İzlanda, Kanada, Romanya
Infliximab	Şili
Remicade	Almanya, Amerika Birleşik Devletleri, Arjantin, Avustralya, Avusturya, Belçika, Birleşik Arap Emirlikleri, Büyük Britanya, Danimarka, Ekvador, Finlandiya, Fransa, Hollanda, İran, İrlanda, İspanya, İsveç, İsviçre, İtalya, İzlanda, Japonya, Kanada, Kolombiya, Lüksemburg, Malezya, Meksika, Norveç, Peru, Polonya, Portekiz, Romanya, Şili, Suudi Arabistan, Tunus, Türkiye, Venezuela, yeni Zelanda, Yunanistan
Remsima	Almanya, Arjantin, Belçika, Büyük Britanya, Ekvador, Fransa, İspanya, İsviçre, İtalya, İzlanda, Kanada, Norveç, Peru, Romanya, Şili, Türkiye
Zessli	Almanya, Belçika, Büyük Britanya

Kaynaklar

Enjeksiyon

Kaynaklar : Infliximab

	tip	yayın
754	Laboratuar	Infliximab (Remicade®) – Summary of Product Characteristics Merck Sharp & Dohme 2019
2296	Laboratuar	Témocilline (Negaban®) - Résumé des caractéristiques du produit Eumedica 2017
3137	Dergi	Beer PM, Wong SJ, Schartman JP, Kulas KE, Hartman CL, Giganti M, Falk NS. Infliximab stability after reconstitution, dilution, and storage under refrigeration. Retina 2010 ; 30, 1: 81-84.
3317	afiş	Guirao S, Paul M, Jaccoulet E, Morand K, Astier A. Stabilité de l'infliximab en solutions diluées. APHIF Congress 2009
3333	Dergi	Ikeda R, Vermeulen L.C, Lau E, Jiang Z, Saha S, Reichelderfer M, Kolesar J.M. Stability of infliximab in polyvinyl chloride bags. Am J Health-Syst Pharm 2012 ; 69:1509-1512.
3825	Dergi	Young B.L, Ali Khan M, Chapman T.J, Parry R,. Connolly M.A, Watts A.G. Evaluation of the physicochemical and functional stability of diluted REMSIMA(R) upon extended storage—A study compliant with NHS (UK) guidance. J Pharm Pract and Res 2015 ; 496: 421-431.
3924	Dergi	Vieillard V, Astier A, Sauzay C, Paul M. One-month stability study of a biosimilar of infliximab (Remsima®) after dilution and storage at 4 C and 25 C. Ann Pharm Fr 2016 ; 75, 1 : 17-29.
4003	Dergi	Kim J, Chung J, Park S, Jung S, Kang D. Evaluation of the physicochemical and biological stability of reconstituted and diluted SB2 (infliximab). EJHP 2017 ; 25, 3: 157-164.
4049	Dergi	Tokhadze N, Chennell P, Le Basle Y, Sautou V. Stability of infliximab solutions in different temperature and dilution conditions. J Pharm Biomed Anal 2018 ; 150 : 386-395
4279	Dergi	Hermosilla J, Sanchez-Martin R, Pérez-Robles R, Salmeron-Garcia A, Casares S, Cabeza J, Cuadros-Rodriguez L, Navas N. Comparative Stability Studies of Different Infliximab and Biosimilar CT-P13 Clinical Solutions by Combined Use of Physicochemical Analytical Techniques and Enzyme-Linked Immunosorbent Assay (ELISA). Bio Drugs 2019 ; 33: 193–205.
4292	Dergi	Vimpolsek M, Gottar-Guillier M, Rossy E. Assessing the Extended In-Use Stability of the Infliximab Biosimilar PF-06438179/GP1111 Following Preparation for Intravenous Infusion. Drugs R D 2019 19: 127–140.

Mentions Légales